Capula Management LTD Moderna, Inc. Put Options Transaction History

Capula Management LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 05, 2024	SELL	$101.21 - $166.61 $212,541 - $349,881	-2,100 Reduced 60.0%	1,400 $166,000
Q1 2024 May 09, 2024	BUY	$85.37 - $115.44 $298,795 - $404,040	3,500 New	3,500 $372,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $4.01 Million - $5.43 Million	-33,800 Reduced 60.68%	21,900 $2.66 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $7.56 Million - $11 Million	55,700 New	55,700 $8.55 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.74 Million - $2.85 Million	14,700 New	14,700 $1.74 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $812,952 - $1.33 Million	-3,600 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $467,676 - $845,928	3,600 New	3,600 $846,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.